Friday, February 14, 2020 12:47:19 PM
learningcurve2020,
You must not have even read the quote you posted. It stated that financing would become more difficult until investors get answers. In Wonderland financing would be done with a much higher share price of $15-s20 right now based purely on the potential of the DCVax platform.
As for Mr. Black, since he came on board Ms. Katherine Wolf lost her posistion at Ondra as a partner and was dismissed. The CEO of Cenkos suddenly resigned without explanation, Mr. Woodford fell out of favor after he got caught with his hands in the NWBO cookie jar along with Ms. Wolf, The Street began loosing value and a certain blogger working for them, who was publicly reprimanded by the head of NWBO's DMC because if his blatant lies, lost his job there and went elsewhere. Then the head of this same DMC resigns after a potential conflict of interest with regard to another company he was connected to doing similar research. Add into this that according to a reported conversation with Les, NWBO knows who the price manipulating perps are and I would say that Mr. Black has been very active behind the scenes. You can say all of this is just coincidence but when the head of FDA also resigns suddenly with nothing much to say after other scandals at FDA had been revealed there seems to be a draining of the swamp without anyone taking credit. Funny how all of these folks might have been or were certainly aware of NWBO and yet NWBO is not known by a vast majority of people. Pure coincidence. Lol. Best wishes.
You must not have even read the quote you posted. It stated that financing would become more difficult until investors get answers. In Wonderland financing would be done with a much higher share price of $15-s20 right now based purely on the potential of the DCVax platform.
As for Mr. Black, since he came on board Ms. Katherine Wolf lost her posistion at Ondra as a partner and was dismissed. The CEO of Cenkos suddenly resigned without explanation, Mr. Woodford fell out of favor after he got caught with his hands in the NWBO cookie jar along with Ms. Wolf, The Street began loosing value and a certain blogger working for them, who was publicly reprimanded by the head of NWBO's DMC because if his blatant lies, lost his job there and went elsewhere. Then the head of this same DMC resigns after a potential conflict of interest with regard to another company he was connected to doing similar research. Add into this that according to a reported conversation with Les, NWBO knows who the price manipulating perps are and I would say that Mr. Black has been very active behind the scenes. You can say all of this is just coincidence but when the head of FDA also resigns suddenly with nothing much to say after other scandals at FDA had been revealed there seems to be a draining of the swamp without anyone taking credit. Funny how all of these folks might have been or were certainly aware of NWBO and yet NWBO is not known by a vast majority of people. Pure coincidence. Lol. Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
